New screening procedure signals risk of CVD at earlier stage.
Begin preventive treatment for CVD before it has a chance to do damage. How? With an innovative screening tool that can non-invasively gauge the elasticity of the small and large arteries--an accepted early marker for CVD. On the market since it was approved by the FDA earlier this year, physicians and managed care organizations have already begun to use the new tool, and hopes are high that it can revolutionize the way patients are screened for this deadly and costly disease.
D000293:Adolescent; D000328:Adult; D001158:Arteries / Q000503:physiopathology; D001795:Blood Pressure Determination / Q000191:economics / Q000379:methods*; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D004059:Diffusion of Innovation; D004548:Elasticity; D006801:Humans; D008329:Managed Care Programs; D008403:Mass Screening / Q000379:methods*; D011320:Primary Health Care; D011674:Pulse; D012307:Risk Factors; D014481:United States / Q000453:epidemiology